Search All News
Columbia-led study hold promise for helping people find therapies that work.
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
Source:ViceMay 16, 2022
"There's no way that these drugs can meet the fantasized expectations that people have,” David Hellerstein, MD, a professor of clinical psychiatry at Columbia, said in reference to psychedelics.
Source:ADAA GotAnxietyMay 3, 2022
Jeff Cohen, a clinical psychologist at Columbia, shares an introduction to dialectical behavior therapy (DBT) as a treatment option.
Source:CNN HealthApril 21, 2022
Melina Wald, director of the Gender Identity Program at Columbia, says that waiting to transition can create additional psychological distress for a child.
Source:Psychiatry AdvisorMarch 11, 2022
Ravi N. Shah, chief innovation officer for Columbia's Department of Psychiatry, discusses the Pathways mobile app.
Source:The New York TimesMarch 11, 2022
“Ketamine is a medical treatment intended to address a significant illness,” such as severe depression or suicidal ideation, said Joshua Berman, assistant professor of psychiatry at Columbia.
- December 13, 2021
New insights into genetic architecture of disease hold promise for improved risk prediction and novel drug design.
- December 8, 2021
Columbia study finds rates are lowest among rural, Black, Hispanic, and Medicaid patients.
- November 17, 2021
Columbia Psychiatry is among the principal investigators in biotech Compass Pathways study of more than 200 patients.
- November 8, 2021
New research at Columbia University Irving Medical Center shows equine therapy can jump-start the healing process for veterans who suffer from posttraumatic stress disorder (PTSD).
- November 2, 2021
Five-year Columbia clinical trial indicates rapid cognitive shift diminishes suicidal thoughts, independently of improvement in depressive symptoms